{"id":"https://openalex.org/W2425305176","doi":null,"title":"[Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].","display_name":"[Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].","publication_year":1995,"publication_date":"1995-01-28","ids":{"openalex":"https://openalex.org/W2425305176","mag":"2425305176","pmid":"https://pubmed.ncbi.nlm.nih.gov/7878401"},"language":"de","primary_location":{"id":"pmid:7878401","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7878401","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Schweizerische medizinische Wochenschrift","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002752896","display_name":"Heinrich Vogt","orcid":"https://orcid.org/0000-0003-3866-3195","observed_orcids":["https://orcid.org/0000-0003-3866-3195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Vogt","raw_affiliation_strings":["Schweizerische Epilepsie-Klinik Z\u00fcrich"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schweizerische Epilepsie-Klinik Z\u00fcrich","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026583601","display_name":"G\u00fcnter Kr\u00e4mer","orcid":"https://orcid.org/0000-0001-7552-8393","observed_orcids":["https://orcid.org/0000-0001-7552-8393"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Kr\u00e4mer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.36480821,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"125","issue":"4","first_page":"125","last_page":"32"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12267","display_name":"Diet and metabolism studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vigabatrin","display_name":"vigabatrin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":1.0},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8629999756813049},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/focal-seizures","display_name":"focal seizures","score":0.6169999837875366},{"id":"https://openalex.org/keywords/complex-partial-seizures","display_name":"complex partial seizures","score":0.921999990940094},{"id":"https://openalex.org/keywords/infantile-spasms","display_name":"infantile spasms","score":0.8029999732971191},{"id":"https://openalex.org/keywords/secondary-generalized-epilepsy","display_name":"secondary generalized epilepsy","score":0.7409999966621399},{"id":"https://openalex.org/keywords/drug-resistant-epilepsy","display_name":"drug-resistant epilepsy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/generalized-seizures","display_name":"generalized seizures","score":0.7009999752044678},{"id":"https://openalex.org/keywords/absence-seizures","display_name":"absence seizures","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tonic-seizures","display_name":"tonic seizures","score":0.5080000162124634},{"id":"https://openalex.org/keywords/seizure-frequency-reduction","display_name":"seizure frequency reduction","score":0.5329999923706055},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.46399998664855957}],"concepts":[{"id":"https://openalex.org/C2780837902","wikidata":"https://www.wikidata.org/wiki/Q421663","display_name":"Vigabatrin","level":4,"score":0.9961323738098145},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.8462502956390381},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8056826591491699},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.6271059513092041},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.620147705078125},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5410135984420776},{"id":"https://openalex.org/C2777803345","wikidata":"https://www.wikidata.org/wiki/Q7140388","display_name":"partial seizures","level":3,"score":0.4844115376472473},{"id":"https://openalex.org/C2780874087","wikidata":"https://www.wikidata.org/wiki/Q7447057","display_name":"Seizure types","level":3,"score":0.46256741881370544},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3765779137611389},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33387261629104614},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1598476767539978}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000612","descriptor_name":"4-Aminobutyrate Transaminase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004828","descriptor_name":"Epilepsies, Partial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004830","descriptor_name":"Epilepsy, Tonic-Clonic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004832","descriptor_name":"Epilepsy, Absence","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013036","descriptor_name":"Spasms, Infantile","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017029","descriptor_name":"Epilepsy, Complex Partial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020888","descriptor_name":"Vigabatrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:7878401","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7878401","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Schweizerische medizinische Wochenschrift","raw_type":"Journal Article"},{"id":"mag:2425305176","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7878401","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2148005800","https://openalex.org/W2161242462","https://openalex.org/W2043559003","https://openalex.org/W2064054004","https://openalex.org/W2416523973","https://openalex.org/W1992656894","https://openalex.org/W2020339970","https://openalex.org/W2057183180","https://openalex.org/W2067324901","https://openalex.org/W2000628471"],"abstract_inverted_index":{"Vigabatrin":[0,13,41],"and":[1,17,47,54,88,116,124,163,208,228],"lamotrigine":[2],"are":[3,175],"two":[4],"new":[5],"antiepileptic":[6],"drugs":[7],"which":[8,201],"have":[9,181,212],"recently":[10],"become":[11],"available.":[12],"is":[14,42,142,152,191,203,216],"a":[15,30,80,233],"specific":[16],"irreversible":[18],"inhibitor":[19],"of":[20,52,69,74,84,90,138,148,158,197],"the":[21,36,50,99,136,146,156,195],"enzyme":[22],"gamma-amino-butyric-acid":[23],"(GABA)":[24],"transferase.":[25],"Its":[26],"administration":[27],"leads":[28],"to":[29,62],"long":[31],"lasting":[32],"increase":[33],"in":[34,44,49,60,67,104,114,145,194,220,226,236],"GABA,":[35],"most":[37],"important":[38],"inhibitory":[39],"neurotransmitter.":[40],"effective":[43,144,193,219],"both":[45],"adults":[46],"children":[48],"treatment":[51,147,157,196],"partial":[53,198],"especially":[55],"complex-partial":[56],"seizures.":[57,118,126,165,222],"After":[58],"add-on":[59,224],"vigabatrin":[61,141,169],"their":[63],"therapeutic":[64],"drug":[65],"regime":[66],"116":[68],"our":[70,209],"own":[71,210],"patients,":[72],"39%":[73],"previously":[75],"therapy":[76,225],"resistant":[77],"patients":[78,120,167],"reported":[79],"reduced":[81],"seizure":[82,93,237,241],"frequency":[83],"at":[85],"least":[86],"50%":[87],"6%":[89],"them":[91],"became":[92],"free.":[94],"In":[95,108,135],"secondarily":[96],"generalized":[97,159,221],"epilepsies":[98,160],"best":[100],"results":[101],"were":[102],"observed":[103],"axial":[105],"(infantile)":[106],"spasms.":[107,150],"addition":[109],"there":[110,180],"was":[111,129],"some":[112],"improvement":[113],"tonic":[115,229],"convulsive":[117],"Single":[119],"showed":[121],"increased":[122],"myoclonic":[123,164],"clonic":[125],"Initial":[127],"efficacy":[128],"not":[130,153],"always":[131],"maintained":[132],"during":[133],"follow-up.":[134],"experience":[137,211],"other":[139],"authors,":[140],"also":[143,192],"infantile":[149],"It":[151],"suitable":[154],"for":[155,200],"with":[161],"absences":[162,227],"Most":[166],"tolerate":[168],"very":[170],"well,":[171],"although":[172],"psychotic":[173],"episodes":[174],"sometimes":[176],"reported.":[177],"So":[178],"far":[179],"been":[182],"no":[183],"relevant":[184],"hepatic":[185],"or":[186,230],"hematological":[187],"side":[188],"effects.":[189],"Lamotrigine":[190],"seizures,":[199,232],"it":[202,215],"approved.":[204],"However,":[205],"uncontrolled":[206],"studies":[207],"shown":[213],"that":[214],"even":[217],"more":[218],"As":[223],"tonic-clonic":[231],"significant":[234],"reduction":[235],"frequency--in":[238],"individual":[239],"cases":[240],"freedom--can":[242],"be":[243],"achieved.(ABSTRACT":[244],"TRUNCATED":[245],"AT":[246],"250":[247],"WORDS)":[248]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}